Western blot analysis further confirmed upregulated IL-33 and its receptor accessory protein IL-1RAcP, reinforcing the transcriptional data and supporting IL-33 pathway activation in PAH (Figure 1F). This evidence concerns the gene IL33 and pulmonary arterial hypertension.